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INTRODUCTION 
Diabetes is an epidemic disease round the world. 
Diabetes frequency of occurrence is rising in most of the 
populations especially in developing countries.
1
 At the 
moment there are 7.5 million diabetic patients in Iran.
2
 
The global epidemic of diabetes mellitus has severely 
increased in last 2 decades and also it has been escalated 
from 30 million in 1985 to 285 million in 2010. If the 
condition keeps going like this, in 2030 there will 438 
million diabetic patients according to diabetes 
international federation’s anticipations. Although the 
prevalence of both diabetes type 1 and type 2 is 
increasing all around the world. But the type 2 diabetes is 
spreading much faster than the type 1. The reasons for 
this phenomenon probably are the rising obesity, 
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Background: Diabetes type 2 associates with increased oxidative stress and reduced antioxidant. Vitamin E 
supplementation reduces oxidative stress in diabetic patients. We intended to measure the level of this vitamin in 
these patients to assess its relationship in control of patients' diabetes by designing present study.  
Methods: This is a descriptive and cross-sectional study and carried out on 186 patients with diabetes type 2 
diagnosis. The levels of HbA1C (measured by HPLC method), TG, cholesterol, HDL, LDL and Cr were measured, 
and given to that the level of HbA1C lower than 7 (controlled group) and or more than 7 (uncontrolled group), 
patients were divided in two groups. Were designed a check list involved questions such as age and information of 
each patient associated with measured vitamin E level were entered into the check list and after that were analyzed 
data.  
Results: In the existing study 186 diabetic patients were examined. From within examined patients, 129 (69.3%) were 
women and the rest were men and average patients age were 53.33±11.2. In this study was observed there was no 
direct correlation between the level of cholesterol (p=0.284), LDL (p=0.538( and HDL (p=0.362) with controlled DM 
II in patients while in uncontrolled diabetic the triglyceride levels was more than those with controlled blood sugar 
significantly (p=0.046(. The average vitamin E level in patients was 1488.6±692.2 nmol/l its lowest level 114.4 
nmol/l and the highest level was 6235 nmol/l.  
Conclusions: The results of this study show that the vitamin E levels no significant difference between control and 
non-control diabetic patients.  
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decreased physical activities (which is due to the 
industrialization) and rising age of communities. In 2010 
almost 1.6 million people (over 20) were diabetic who 
have been diagnosed recently. The risk of diabetes 
mellitus rises as age increases. In 2010, the prevalence of 
diabetes mellitus in United States was estimated 0.2% in 
less than 20 years and 11.3% in over 20 years old. In the 
people over 65 diabetes mellitus’ prevalence was 26.9%. 
The prevalence of this disease is almost as same as in all 
age ranges in men and women (11.8% in men over 20 
and 10.8% in women over 20) global estimations predict 
that in 2030, the most of the diabetics will be in range of 
45 to 64 years.
3
 The studies of the control of diabetes and 
its side effects have indicated that the diabetes side effect 
can be delayed or reduced with the control of the severe 
glycemic.
4
 In the last decade there have been some 
considerations over oxidative stress and its role in 
causing side effects in diabetic patients.
5
 Lots of studies 
have indicated the high levels of oxidative stress 
markers.
6
 The increase in levels of insulin, free fatty acids 
and glucose can cause an increase in ROS and oxidative 
stress and also it can activate the stress sensitive 
pathway.
7
 In last years it has been known that the most 
important factor in producing free radicals in diabetes is 
hyper glycaemia, which increases the production of 
superoxide radical in mitochondria.
8
 It has been reported 
that the levels of alpha tocopherol in type 2 diabetic 
patient’s plasma is lower than the healthy people.9 The 
alpha tocopherol prescription can cause a delay in chronic 
side effects of diabetes.
10
 Also alpha tocopherol has 
beneficial effects on metabolically control in diabetes by 
its anti-oxidation effects on lipid oxidation, protein 
glycosylation and its sensitivity to insulin.
11
 The results 
of a 4 year old cohort study showed that for each 1 
micromol/l decrease in alpha tocopherol plasma levels. 
The risk of diabetes rises about 22%.
12
 Also other study 
showed that consuming vitamin e in diabetic patients can 
significantly decrease levels of micro albuminuria and 
thromboxane A2 in patients with micro albuminuria.
13
 
Other study was about effects of vitamins E and C on fat 
profile in patients with diabetes mellitus. The results of 
this study showed that consumption of vitamins E and C 
can significantly decrease hypertension and cause 
remission in insulin activity and fat profile.
14
 Studies 
showed that vitamin E has an important effect on 
decreasing blood pressure and blood glucose in type 2 
diabetic patients.
15
 Of course other studies say that 
vitamin E cannot ameliorate glucose levels of patients.
16
 
In a research done by Onyesom and et al, vitamin a 
(14.38 µg/l), vitamin c (0.66 mg/dl) and vitamin e (0.51 
mg/dl) levels were lower in recently diagnosed diabetic 
patients comparing to control group (healthy) (p<0/05). 
diabetic patients have 30 % shortage of vitamin a, 36% 
shortage of vitamin C and 12% shortage of vitamin E.
17
 
By considering previous studies and the effect of vitamin 
e supplements in diabetic patients, this study was done to 
measure vitamin e in controlled and uncontrolled patients 
with diabetes mellitus type 2 and to study its link in 
controlling diabetes in diabetic patients. 
METHODS 
Existing study is a descriptive analytic cross-sectional 
study and it’s been done in diabetes clinic of Imam 
Khomeini hospital in Ardabil (Feb-2014 to May-2015). 
Statistical society of this study was diabetic patients who 
referred to diabetes clinic of Imam Khomeini hospital for 
chemotherapy. (Sampling census method was done until 
the completion of sample size). Sample size was 
determined 186 individuals by following formula with 
test ability of 80%, confidence level of 95%, error of 5% 
and diabetes prevalence of 6%.
18
  
N= (Zα/2+Zβ) 2×P×Q ∕ d2 
Zα/2 = 1.96, Zβ = 0.85, P= 0.06, Q=0.94, d = 0.05, Power 
= 80% 
Exclusion criteria’s in this study are unwillingness of 
patients for cooperating, having underlying diseases, 
being smoker and consuming nutritional supplements. In 
this study 186 patients with diabetes type 2 who were 
having chemotherapy were selected. After blood 
sampling patients, the levels of HbA1C (measurement 
with HPLC method), TG, cholesterol, HDL, LDL, Cr and 
vitamin E (measurement with Eliza method) were 
measured. And by considering patients; HbA1C they 
were divided through two groups: less than 7 (controlled 
group) and more than 7 (uncontrolled group). Food 
consumption of patients were asked for 3 times a week 
(2
nd
 and 3
rd
 times were reminiscent) to check the food 
frequency and after entering the amount of daily 
consumed food to N4 food analysis program. Amounts of 
calorie, protein and etc. in consumed food were 
calculated. The calculated numbers were divided by 3 
and the resulted numbers showed the amount of 
consumed food in one day (the average of 3 days in 
week) and the results were entered in checklists. In 
checklists, questions about age, gender, weight, height, 
length of being diabetic, living in urban or rural and diet 
were asked (based on a standard questionnaire) and 
patient’s information with measured levels of vitamin e 
entered checklist and eventually data were analyzed. 
After data being collected, they were coded and entered 
SPSS V16 statistical software. After wards, after using 
analytical statistical methods such as t-test and Pierson 
statistical exam, data were analyzed with descriptive 
statistical methods. In all mentioned tests, test error 
significance for confidence level was 0.95 less than 0.05. 
For obeying principles of medical ethics, information was 
maintained confidentially and results were reported 
without mentioning names. Patient’s unwillingness of 
cooperating in performing tests, high costs of tests and 
overdosing vitamin supplements by patients were the 
restrictions of study. 
RESULTS 
In the existing study 186 diabetic patients were 
examined. From within examined patients, 129 (69.3%) 
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were women and the rest were men and average patients 
age were 53.33±11.2. From 186 patients, 158 (84.9%) 
were burgess and 28 (15.1) were rural and 171 patients 
(91.9%) were from Ardabil. Results showed that most of 
the patients (114 individuals) (61.3%) have used only 
insulin to control their blood sugar. 90 patients (48.4%) 
had history of using lipid lowering drugs and the rest 
(51.6%) didn’t. Results showed that 144 patients (77.4%) 
had positive diabetes type 2 in family history. And 2 
patients (1%) had a history of diabetes type 1 and average 
period of time for being diabetic in patients were 8.4±6.6. 
Also patients BMI average was 28.32±4.1 (kg/m
2
). 
Results showed that average levels of blood sugar in 
patients were 217.5±100.5 mg/dl. The least blood sugar 
level was 60 mg/dl and highest was 846 mg/dl. Average 
of HBA1C levels of patients was 8.95±2.2. The least 
HBA1C level was 5 and the highest was 18.1. 
Cholesterol, triglyceride, HDL, and LDL levels were 
mentioned in Table 1 below. 
Table 1: Result of on lipid profile in patients with diabetes. 
Test Cholesterol (mg/dl) Triglyceride (mg/dl)  LDL (mg/dl) HDL (mg/dl) 
Mean (mg/dl)±SD 198.3±49 195.1±107.24  106.05± 43.5 49.32± 14.90 
Variance 2400 132.2 345.2 222.2 
variation range 291 676 230 86 
Minimum scores (mg/dl) 55 40 50 16 
Maximum scores (mg/dl) 346 716 230 102 
Table 2: Results of liver enzymes in patients with diabetes. 
AST(IU/l) ALT(IU/l) Test 
186 186 Number of samples 
26.64±17.2 25.78±16.02 Mean(IU/l)±SD 
259.8 256.6 Variance 
172 137 variation range 
5 4 Minimum scores (IU/l) 
177 141 Maximum scores (IU/l) 
Table 3: Results of calories, protein and fat intake in patients with diabetes. 
Fat(g/l) Protein (g/l)  Calories (KJ)  Test 
186 186 186 Number of samples 
55.8±25.67 81.15±72.9 1605.4±432.4 Mean±SD 
658.9 5316.2 7769.6 Variance 
151 995.6 2090 variation range 
12 4.4 980 Minimum scores 
163 1000 3070 Maximum scores 
Table 4: level Average of parameters in controlled diabetic patients and with patients of uncontrolled diabetes. 
level average of parameters 
Mean±SD  
Controlled diabetic patients 
(n=97) 
Uncontrolled diabetic 
patients (n=89) 
P value 
Vitamin E 1548.4±777.3 1423.4±583 0.214 
Cholesterol 194.6±43.87 202.3±53.99 0.284 
Triglyceride 179.9±94.17 211.7±118.2 0.046 
LDL 107.9±39 103.9±48.18 0.538 
HDL 48.4±14.3 50.3±15.6 0.362 
Food Glucose 4.06±3.92 4.3±3.5 0.65 
Food Protein 88.66±97.5 72.96±26 0.143 
Food Fat 56.45±26.8 55.13±24.4 0.728 
Food Weight 1292.8±326.8 1260.6±348.9 0.51 
 
Results showed that Average Levels of vitamin E in 
patients, 692.2±1488.6 (nmol/l), and the lowest level of 
114.4 nmol/l and the maximum level was 6235 nmol/l. 
Also Average levels of ALT and AST was ALT 
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25.78±16.2IU/L and mean levels of AST in patients 
26.64±17.2 IU/l (Table 2). 
The level of calories, protein and fat patients are given in 
Table 3. 
Also average of received vitamin E in diabetic patients 
food was 4.53±4.24 nmol/l. Patients’ average received 
food weight was 1277.4±337.01 gr. Patients were divided 
in two groups based on HBA1C level, first group was 
equal or less than 7 (controlled) second group was more 
than 7 (uncontrolled). At this point, 97 of the patients 
were controlled (52.2%) and the rest of the diabetic was 
uncontrolled. 
Results showed that there wasn’t any significant 
difference between vitamin E level and cholesterol level 
within controlled diabetic patients and uncontrolled 
diabetic patients. This study showed that average of 
triglyceride is higher in uncontrolled group and by 
considering that, this difference was statistically 
significant (p=0.046). analysis have shown that there isn’t 
any significant difference between LDL levels within 
controlled diabetic patients and uncontrolled diabetic 
patients (p=0.538) and also difference between HDL 
levels in uncontrolled patients are higher than HDL levels 
in controlled patients but this difference is not statistically 
significant. On the other hand results showed that average 
of food glucose (gr/kg) in uncontrolled group is higher 
than controlled patient. but this difference was not also 
statistically significant and average of protein levels in 
food is higher in controlled patients comparing to 
uncontrolled patients but this difference wasn’t 
statistically significant either and average of food fat 
levels and weight is lower in uncontrolled diabetic 
patients comparing to controlled patient but this 
difference also wasn’t statistically significant by 
considering this fact that significance level of test error 
for confidence level was 0.95 out of 0.66 and it was more 
than 0.05, so it could be said that there is no link between 
vitamin e and food vitamin e levels. 
Table 5: Results of Pearson correlation coefficient to determine correlation between levels of vitamin E, and food 
vitamin E. 
Level of food Vitamin E Level of Vitamin E Parameters 
0.032 1 Pearson correlation coefficient 
Level of Vitamin E 0.66 - Significance level 
186 186 Number of samples 
1 0.032 Pearson correlation coefficient Level of food Vitamin E 
 
DISCUSSION 
Vitamin E is one of the anti-oxidant vitamins which are 
being reduced by eliminating free radicals. Escalation of 
plasma glucose and glycemic index can increase oxygen 
free radicals. Therefor it’s likely that vitamin E levels in 
diabetic patients are lower than healthy individuals and in 
individuals with weak blood sugar control it’s lower than 
low glycemic diabetic patients.
19
 In the existing study it 
was observed that there wasn’t any direct link between 
cholesterol (p=0.284), HDL (p=0.362) and LDL 
(p=0.538) levels and blood sugar control. But in 
uncontrolled diabetic patient s triglyceride levels were 
significantly higher individuals with blood sugar control 
(p=0.046). In a study of Taheri et al serum total 
cholesterol, triglyceride and LDL in diabetic patients 
were higher than control group but HDL serum level 
were lower than control group.
20
 This diversity was more 
significant about triglyceride. In a study of Esteghamat I 
and et al.
21
 blood glucose level glycolysed hemoglobin, 
total cholesterol, triglyceride and LDL-C had a 
significant rise in type 2 diabetic patients but HDL-C was 
decreased. In a study of Ahmad and et al it was observed 
that LDL and VLDL levels in diabetic patients were 
higher than health individuals (p<0.001). And also HDL 
levels in diabetic patients were lower than control group 
(p<0.001). in a study of Sawant and et al.
22
 it was 
observed that FBG and HBA1C levels in diabetic patients 
without any neuropathy were lower than in diabetic 
patients with neuropathy (p<0.05). In a study of Gazis 
and et al.
23
 it was observed that in diabetic patients 
HBA1C (6.9 vs. 4.8, p<0.01) and systolic blood pressure 
(145 vs 130, p<0.01) levels were significantly divers but 
diastolic blood pressure levels was not different 
comparing to healthy individuals. 
In the existing study average vitamin e levels in patient s 
are 1488.6±692.2 nmol/l and lowest is 114.4 nmol/l and 
highest is 6235 nmol/l. Also data analysis indicate that 
there isn’t any significant difference in vitamin e levels 
between diabetic controlled patients and uncontrolled 
patients (p=0.214). in the study of Esteghamati et al 
vitamin e and c levels in diabetic patients plasma  didn’t 
change at all comparing to control group, although 
vitamin e to cholesterol ratio decreased (p<0.05).
21
 In a 
study of Srivatsan et al it was observed that vitamin e 
level in control group was 1.08 mg/dl, in diabetic patients 
with side effects was 1.19 mg/dl and in diabetic patients 
without side effects was 1.17 mg/dl and also there wasn’t 
any significant diversity between vitamin e levels and 
studied group (p=0.64).
24
 In a study of Ahmad et al it was 
observed that vitamin e and c levels in diabetic 
individuals were lesser than control group (p<0.001) and 
there wasn’t any significant diversity in vitamin a levels 
between two groups.
9
 In a study of Oneysom et al it was 
observed that vitamin a (14.38 microgram/l), vitamin c 
(0.66 mg/dl) and vitamin e (0.51 mg/dl) level in recently 
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diagnosed diabetic patients were lesser than control 
(healthy) group’s  individuals (p<0.05).17 Diabetic 
patients have about 30% vitamin a deficiency, 36% 
vitamin c deficiency and 12% vitamin e deficiency. In a 
study of Sawant et al it was observed that vitamin e level 
in diabetic patients without neurologic side effects  is  
1153 and in diabetic patients with neurologic side effects 
(neuropathy) is 730 and this diversity was statistically 
significant (p<0.05).
22
 
In a study of Salonen and et al after patient follow up and 
also measurements of vitamin e in them, it was observed 
that vitamin e deficiency can increase the diabetes risk to 
3.9 times.
12
 Decrease in vitamin e serum density about 1 
mumol/l, can increase diabetes risk about 22%. In a study 
of Dogon and et al it was observed that vitamin e and c 
levels in diabetic patients were significantly lesser than 
individuals of control group.
25
 In a study of Dosoo and et 
al it was observed that antioxidant status in diabetic 
patients with the receiver of sugar lowering tablets 
(NIDDM) was significantly lower than healthy 
individuals (p<0.001).
26
 Also it was observed that with 
the increase in fasting glucose, anti-oxidant levels 
decreased significantly. Good control of fasting glucose 
in patients resulted in decrease in free radicals. And 
increase in antioxidant levels. 
In a study of Odum and et al.
27
 it was observed that 
average of total antioxidant (1180 micromol/l), vitamin c 
(26.59 micromol/l) and vitamin e (1533 micromol/l) in 
diabetic patients were significantly lower than healthy 
individuals (in all cases p=0.0001) in a study of Lapolla 
and et al it was observed that vitamin e level and total 
antioxidant status in diabetic patients with peripheral 
arterial disease (ABI<0.9) were lower than diabetic 
patients without periphra arterial disease.
28
 
In the most of the studies among them in Baliarsingh et 
al, de Oliveira et al, Baolissi et al and also in park and et 
al vitamin e deficiency in diabetic patients was lower 
comparing to control patients and this low deficiency was 
considered as a risk factor (OR>1).
29-32
 In a study of Ble 
Castillo and et al this vitamin again was higher in diabetic 
patients comparing to healthy individuals and these high 
levels were considered as a protection factor (OR<1).
33
  
In the other studies among them in Reaven et al and also 
Economides and et al the vitamin levels were not 
significantly different in both groups and also both 
groups’ diabetic individuals were almost as same as non-
diabetic individuals.
34,35
 
After studying several related researches it was observed 
that the most of them were about studying vitamin e 
levels in diabetic patients and health individuals. So by 
considering this vitamin e levels in most of the studies 
vitamin e levels in diabetic patients were significantly 
lower than healthy individuals. But in this study thence 
vitamin e levels were controlled or uncontrolled in 
diabetic patients. These vitamin levels were not 
significantly different. Also in most of the researches 
vitamin e effect on diabetic patients was studied. For 
example in a study of Khabbaz et al it was observed that 
vitamin e prescription can decrease FBS (fasting blood 
sugar) and triglyceride but however this de-escalation 
was not significant.
36
 Total cholesterol, systolic and 
diastolic blood pressure levels didn’t change 
significantly. In the study of Vieira and et al it was 
observed that treatment with alpha tocopherol can cause 
de-escalation in systolic hypertension and LDL and also 
escalation in HDL levels but it cannot significantly 
change triglyceride and total cholesterol levels.
37
 In the 
study of Gazis and et al it was also observed that vitamin 
e prescription cannot cause vasodilation in diabetic 
patients.
23
 In the study of Paolisso et al
 
it was observed 
that long term vitamin e prescription can lower plasma 
glucose (p>0.05), triglyceride (p<0.02), free fatty acids 
(p<0.05), total cholesterol (p<0.05), LDL (p<0.04), 
HbA1C (p<0.05) and apportion B (p<0.05) but however 
it couldn’t lower insulin resistance.31 
In the study of Khabbaz and et al it was observed that 
vitamin e prescription with 800 units in a day for 3 month 
cannot ameliorate blood sugar, blood fat, glycolised 
hemoglobin levels, fasting insulin and blood pressure in 
type two diabetic patients.
36
 In the study of Lonn and et al 
it was observed that daily prescription of 400 unit’s 
vitamin e has absolutely no effect on decreasing the 
possibility of cardiovascular diseases in diabetic 
patients.
38
  
In the study of Boshtam and et al it was observed that 
daily prescription of 200 unit’s vitamin e in diabetic 
patients caused an insignificant de-escalation in FBS 
levels and insulin resistance.
39
 The prescription of the 
vitamin also couldn’t make a change in triglyceride and 
total cholesterol levels.  
In the study of Susomboon and et al.
16
 which was a 
systemic study/ it was observed that in 9 studies, vitamin 
e supplements couldn’t decrease blood sugar levels in 
diabetic patients. also it was observed that vitamin e 
decreased blood sugar in patients with uncontrolled blood 
sugar (HbA1C>8%) and also this vitamin was lower in 
patients with uncontrolled blood sugar (HbA1C>8%). 
The results of these researches indicate that vitamin e 
prescription does not have significant effect on lowering 
diabetes side effects. By considering  achieved results  
from existing research, it has been suggested that by 
considering  insignificant diversity in both controlled and 
uncontrolled diabetic groups and also similar studies 
which have been done in other countries to not to 
prescribe antioxidant vitamins such as vitamin e 
unreasonably and without indications due to 
unaffordability and also patients non-compliance for 
taking too much drugs. And the prescription of these 
kinds of drugs should be only limited to specify 
indications such as triglyceride, fatty liver and etc. but of 
course this needs more research too. In this study health 
individuals’ group was not studied as a control group. 
Hence in comparing to the most of the studies which had 
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control group we couldn’t do a good comparison by 
vitamin e levels significance.  In this study vitamin c and 
other antioxidants were not studied. 
CONCLUSION  
Results of existing study indicated that there is absolutely 
no significant diversity between controlled and 
uncontrolled diabetic individuals in vitamin E levels. 
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